Shape Memory Medical

Shape Memory Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $65M

Overview

Shape Memory Medical is a pioneering medical device firm leveraging a proprietary shape memory polymer platform to develop next-generation embolization devices. Founded in 2008, the company's technology aims to improve procedural outcomes by providing devices that conform to patient anatomy, are radiolucent for visibility, and bioabsorb while promoting healthy tissue regeneration. It is currently commercializing its IMPEDE Embolization Plug family and developing a broader portfolio for cross-specialty vascular applications, positioning itself as a potential disruptor in the embolotherapy market.

CardiovascularPeripheral VascularNeurovascular

Technology Platform

Proprietary shape memory polymer (SMP) engineered for embolization. Key features include regenerative bioabsorption that promotes healthy collagen formation, dynamic conformability to vessel anatomy, radiolucency for imaging clarity, and high porosity for rapid clot formation.

Funding History

3
Total raised:$65M
Series C$35M
Series B$20M
Series A$10M

Opportunities

The large and growing global embolization device market presents a significant opportunity to displace traditional metal coils and liquid embolics with a superior smart polymer technology.
The platform's unique benefits—bioabsorption, conformability, and imaging clarity—allow it to address unmet needs across peripheral, neurovascular, and aortic specialties, enabling a broad, cross-specialty portfolio.

Risk Factors

Key risks include commercial execution against large, entrenched competitors, the need for extensive long-term clinical data to prove superior efficacy and healing claims, and ongoing dependence on external financing to fund growth and development in a capital-intensive sector.

Competitive Landscape

Shape Memory Medical competes in the embolization device market against major medical device companies like Boston Scientific, Medtronic, Terumo, and Stryker, which offer metal coils, liquid embolics, and occlusion plugs. Its differentiation is based on its smart polymer's material properties, which aim to combine the immediate occlusion of coils with bioabsorption and promoted healing, a combination not offered by current market leaders.